SafeBoosC-II
Official title: A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life
Trial start year: 2012
Trial start year: 2012
Design paper
2013
A phase II randomized clinical trial on cerebral
near-infrared spectroscopy plus a treatment
guideline versus treatment as usual for extremely
preterm infants during the first three days of life
(SafeBoosC): study protocol for a randomized controlled trial.
Download full paperResult paper
2015
Cerebral near infrared spectroscopy oximetry in
extremely preterm infants: phase II randomised clinical
trial.
Download full paper